About Fluent BioSciences
Fluent BioSciences is a company based in Watertown (United States) founded in 2018 by Sepehr Kiani, Bill Hyun, Adam Abate, and Gary Zweiger was acquired by Illumina in July 2024. Fluent BioSciences has raised $19 million across 2 funding rounds from investors including Illumina, NIH SBIR/STTR and Illumina Ventures. Fluent BioSciences offers products and services including PIPseeker Software and User Guide. Fluent BioSciences operates in a competitive market with competitors including GenScript, Neogen, Parse Biosciences, Sino Biological and Qiagen, among others.
- Headquarter Watertown, United States
- Founders Sepehr Kiani, Bill Hyun, Adam Abate, Gary Zweiger
- SectorsHealthcare
- Email••••••••
- Website fluentbio.com
- Social LinkedIn
- Acquired by Illumina (Jul 2024)
Products & Services of Fluent BioSciences
Fluent BioSciences offers a comprehensive portfolio of products and services, including PIPseeker Software and User Guide.
Analyzes single cell RNA sequencing data and generates metrics.
Provides instructions for using PIPseeker software effectively.
Funding Insights of Fluent BioSciences
Fluent BioSciences has successfully raised a total of $19M across 2 strategic funding rounds. The most recent funding activity was a Grant round of $1.7 million completed in March 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19M
- Total Rounds 2
- Last Round Grant — $1.7M
- First Round $19M
(Jun 2020)
- Investors Count 6
All 2 funding rounds of Fluent BioSciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2022 | $1.7M | Grant | – | – | |
| Jun 2020 | $19M | Series A | – | Illumina Ventures, Samsara BioCapital |
7 investors in total: 7 institutional.
Investors in Fluent BioSciences
Fluent BioSciences has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Illumina, NIH SBIR/STTR and Illumina Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | sbir.nih.gov | - | |
Health tech startups are invested in by Illumina Ventures. | – | illuminaventures.com | Foster City, United States | |
Venture capital funding is provided by Samsara BioCapital in California. | – | samsaracap.com | Palo Alto, United States | |
VC fund investing in startups | – | cowinvc.com | Suzhou, China | |
Venture capital firm investing in the life sciences sector | – | vc23investors.com | Avon, United States | |
Venture capital is provided to health tech and biology innovations. | – | civilizationventures.com | San Francisco, United States | |
Developer of technologies for analysis of genetic variation and function | 1993 | illumina.com | San Diego, United States |
Investor details for Fluent BioSciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Fluent BioSciences
12 people are tracked at Fluent BioSciences (6 in leadership, 3 in board & advisors, 3 in team).
| Name | Role | Group |
|---|---|---|
Sepehr Kiani | Founder & CEO & President | Leadership |
Bill Hyun | Founder | Leadership |
Adam Abate | Founder | Leadership |
Gary Zweiger | Founder | Leadership |
Brian McKernan | CEO | Leadership |
William (Bill) Hyun | Board Member and Co-Founder | Leadership |
Mike Dybbs | Board Member | Board & advisors |
Tony Godfrey | Science Adviser | Board & advisors |
Wouter Meuleman | Board Member | Board & advisors |
Cam LaJeunesse | Lab And Operations Manager | Team |
Sosy Mooradian | Business Operations Manager | Team |
Khalid Williams | Laboratory Technician II | Team |
Complete people profiles for Fluent BioSciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Fluent BioSciences
4 dated milestones of Fluent BioSciences across 6 years, from founding to its latest funding, stage changes and deals.
- Founded Fluent BioSciences is founded.
- Funding First funding round of $19.0M.
- Funding Latest funding round, Grant, of $1.7M.
- Exit Acquired by Illumina.
Competitors of Fluent BioSciences
Fluent BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Neogen, Parse Biosciences, Sino Biological and Qiagen, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| genscript.com | 2002 | Piscataway, United States | $15M | 5,260 | Reagents and instruments are provided for life sciences research. | |
| neogen.com | 1982 | Lansing, United States | $700,000 | 2,640 | Manufacturer of products in the areas of veterinary diagnostics, life sciences, DNA testing, and drug testing | |
| parsebiosciences.com | 2018 | Seattle, United States | $100.26M | – | RNA-sequencing transcriptome kits for health data analysis are developed. | |
| sinobiological.com | 2007 | Beijing, China | $29.41M | – | Reagents and kits are provided for clinical research applications. | |
| qiagen.com | 1984 | Hilden, Germany | – | 104 | Products and reagents for molecular diagnostic assays are supplied. | |
| biofidelity.com | 2002 | Cambridge, United Kingdom | $59.91M | 28 | Molecular diagnostic assays are developed for target DNA sequence detection. | |
| oncodna.com | 2012 | Charleroi, Belgium | $44.53M | 37 | Genomic and theranostic services for oncology precision medicine are delivered. | |
| inscripta.io | 2015 | Helsinki, Finland | $853,384 | – | Speech recognition solutions are provided by Inscripta for healthcare professionals. | |
| rarecyte.com | 2009 | Seattle, United States | $114.33M | 54 | Developer of technologies for the analysis of rare and single cells in the blood |
Detailed competitors of Fluent BioSciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Fluent BioSciences
The website of Fluent BioSciences (fluentbio.com) receives about 4.7K visits a month.
- Monthly visits4.7K
▲ 62.2% vs previous month
Websites whose visitors overlap most with Fluent BioSciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biolabs.io | 100% | – | #967,548 | View details | |
| unchainedlabs.com | 98% | 26.8K | #1,090,394 | View details | |
| rna-seqblog.com | 80% | – | #669,184 | View details | |
| biocat.com | 76% | 37.9K | #866,969 | View details | |
| illumina.com | 76% | 672.7K | #61,793 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 22 similar websites and full traffic analytics for Fluent BioSciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 22 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Fluent Biosciences
Complete news archive for Fluent BioSciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Fluent BioSciences
10 companies that operate in the same segment as Fluent BioSciences (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Fluent BioSciences
Fluent BioSciences was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Fluent BioSciences is headquartered in Watertown, United States.
Sepehr Kiani is the current CEO of Fluent BioSciences. They have also founded this company.
Fluent BioSciences is a funded company, having raised a total of $19M across 2 funding rounds to date. The company's 1st funding round was a Series A of $19M, raised on Jun 2020.
Fluent BioSciences was founded in 2018 and is headquartered in Watertown, United States. Operations focus on the biotechnology sector, where a proprietary reagent known as Pre-templated Instant Partitions (PIPs) is developed. This reagent facilitates the self-assembly of individual cells or molecules into uniform partitions for nucleic acid preparation. Applications include DNA and RNA sequencing as well as single-cell molecular analysis.
Fluent BioSciences's top competitors include Neogen, Sino Biological and Qiagen.
Fluent BioSciences offers PIPseeker Software and User Guide.
Fluent BioSciences has 7 investors. Key investors include Illumina, NIH SBIR/STTR, Illumina Ventures, Samsara BioCapital, and Co-win Ventures.
Yes. Fluent BioSciences was acquired by Illumina in July 2024.